Article Details
Retrieved on: 2025-04-12 13:09:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Remdesivir (RDV) was the first antiviral approved for mild–to–moderate COVID-19 and for those patients at risk for progression to severe disease ...
Article found on: bmcinfectdis.biomedcentral.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here